首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Nicola Marconato,Orazio De Tommasi,Dino Paladin et al. Nicola Marconato et al.
Challenges related to dynamic tumor evolution and the interpretation of HRD status in recurrent disease settings are also addressed.
Hai Chen,Jingmin Shu,Rekha Mudappathi et al. Hai Chen et al.
Intratumor heterogeneity arises from ongoing somatic evolution complicating cancer diagnosis, prognosis, and treatment. Here we present TEATIME (es t imating e volution a ry events t hrough s i ngle-ti m epoint s e quencing), a novel comput...
Philip Falk,Sofie Olsson Hau,Hedda Jacobsen et al. Philip Falk et al.
Background: Malignancies of the liver and bile ducts are associated with high recurrence rates after surgery and poor prognosis when disseminated. Medical treatment has been improved in recent years, with chemotherapy, ta...
Fanghao Li,Xinran Xu,Zhiyuan Wang et al. Fanghao Li et al.
Microplastics (MPs) are omnipresent environmental pollutants posing potential impacts on organisms. To explore the transgenerational effects of polystyrene nanoplastics (PS-NPs) and the molecular mechanisms at environmental relevant concent...
Qiu-Luo Liu,Zong-Guang Zhou,Ziqiang Wang et al. Qiu-Luo Liu et al.
Metastasis, a significant hurdle in cancer treatment, is driven by genetic alterations that shape tumor evolution and dissemination. Traditionally viewed as a late-stage event, recent evidence suggests that metastasis may initiate earlier in tumor progression than previously assumed.
Na Qin,Zhoufeng Wang,Xianfeng Xu et al. Na Qin et al.
Deciphering the timing of driver mutations may lead to insights into tumor evolution that can inform diagnostic and therapeutic approaches for LUAD.
Xiaojuan Yang,Ying Zhou,Buzhe Zhang et al. Xiaojuan Yang et al.
These chromosomal alterations may play a significant role in tumor evolution and treatment resistance. Our findings suggest that irradiation-induced p62 accumulation is crucial for chromothripsis and may affect nuclear repair processes, impacting chromosomal stability.
D Cerrone,D Riccobelli,S Gazzoni et al. D Cerrone et al.
The framework exploits a diffuse-interface mathematical model to describe the tumor evolution and a reduced-order modeling strategy, relying on proper orthogonal decomposition, trained on synthetic data derived from patient-specific brain anatomies reconstructed from magnetic resonance imaging and diffusion...A neural network surrogate learns the inverse mapping from tumor evolution to model parameters, achieving significant computational speed-up while preserving high accuracy.
Ying Han,Cuicui Qiu,Fuping Gao et al. Ying Han et al.
The analysis of tumor metastasis-associated proteins is of vital importance for monitoring tumor evolution and evaluating therapeutic outcomes of protein-targeted drugs.
Youya Wang,He Li,Qinglan Li et al. Youya Wang et al.
Extrachromosomal circular DNA (eccDNA) has emerged as a critical factor in tumor evolution and drug resistance. However, the specific contribution of eccDNA to cisplatin resistance in HGSOC remains unclear.
耗时 0.15076 秒,为您在 48229835 条记录里面共找到 1066 篇文章 [XML]